| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:2334-2341.)
© 2006 American Heart Association, Inc.
Imaging |
From the Departments of Internal Medicine 2 (D.R., F.P., T.P., W.G.D., S.A.) and Diagnostic Radiology (A.K., K.A., W.B., U.B.), University of Erlangen, Erlangen, Germany.
Correspondence to Dr Stephan Achenbach, Medizinische Klinik 2, Universitätsklinikum Erlangen, Ulmenweg 18, 91054 Erlangen, Germany. E-mail stephan.achenbach{at}rzmail.uni-erlangen.de
Received March 31, 2006; revision received September 22, 2006; accepted September 29, 2006.
| Abstract |
|---|
|
|
|---|
Methods and Results Fifty patients with a total of 138 CABG (34 mammary grafts, 3 radial grafts, 101 venous grafts) were investigated by MDCT (0.6-mm collimation, 32 detector rows, 2 focal points, 330-ms rotation) 9 to 252 months (mean, 106 months) after surgery. CABG and all native coronary arteries with a diameter of >1.5 mm were evaluated for the presence of significant stenoses (
50% diameter reduction). Results were compared with quantitative coronary angiography. By MDCT, all CABG were evaluable and were correctly classified as occluded (n=38) or patent (n=100). Sensitivity for stenosis detection in patent grafts was 100% (16/16) with a specificity of 94% (79/84). For the per-segment evaluation of native coronary arteries and distal runoff vessels, sensitivity in evaluable segments (91%) was 86% (87/101) with a specificity of 76% (354/465). If evaluation was restricted to nongrafted arteries and distal runoff vessels, sensitivity was 86% (38/44) with a specificity of 90% (302/334). On a per-patient basis, classifying patients with at least 1 detected stenosis in a CABG, a distal runoff vessel, or a nongrafted artery or with at least 1 unevaluable segment as "positive," MDCT yielded a sensitivity of 97% (35/36) and specificity of 86% (12/14).
Conclusions We found that 64-slice MDCT permits the evaluation of bypass grafts and the assessment of the native coronary arteries for the presence of stenosis.
Key Words: angiography bypass computed tomography imaging tomography
| Introduction |
|---|
|
|
|---|
Clinical Perspective p 2341
In this study, the accuracy of 64-slice MDCT coronary angiography for the evaluation of patients after coronary artery bypass surgery was assessed. Bypass grafts, distal anastomosis sites, and the native coronary artery system were included in the analysis. Results were compared with invasive quantitative coronary angiography.
| Methods |
|---|
|
|
|---|
MDCT Protocol
Patients with a heart rate of >60 bpm received 100 mg atenolol (Tenormin, AstraZeneca, Wedel, Germany) orally 1 hour before the scan. If the heart rate was still >60 bpm at the time of the MDCT investigation, up to 4 doses of 5 mg metoprolol (Beloc, AstraZeneca, Wedel, Germany) were administrated intravenously to lower the heart rate to
60 bpm. In addition, all patients received 0.8 mg isosorbide dinitrate sublingually immediately before MDCT scanning. MDCT was performed with the use of a SOMATOM Sensation 64 Cardiac CT scanner (Siemens Medical Solutions, Forchheim, Germany). The number, type, and location of the bypass grafts were known by the operators of the CT scanner. First, a noncontrast posteroanterior projectional image of the chest was acquired to determine the position of the heart and aortic arch and to define the scan volume for further imaging. Then the contrast agent transit time was determined with a bolus injection of 10 mL contrast agent, followed by 50 mL saline solution, as previously described.19 To reduce radiation dose, and similar to previous studies,2,3,5,6 the origin and very proximal part of the internal mammary artery grafts were not covered by the scan volume. Instead, the upper level was set at the midlevel of the aortic arch. For acquisition of the volume data set, the patients received a total of 80 mL of contrast agent (Omnipaque370, Schering, Berlin, Germany) at a rate of 5 mL/s followed by 50 mL saline solution (also at 5 mL/s). Scan parameters for the volume data set were as follows: simultaneous acquisition of 64 slices per rotation with a slice thickness of 0.6 mm, rotation time 330 ms, table feed 3.8 mm per rotation, tube voltage 120 kV, and tube current 750 mA. ECG-gated tube current modulation was used in all patients. It limits the full tube current to a time period of 450 ms in diastole and thus leads to a reduction of the radiation dose of
50%.12,20,21 Radiation dose was estimated with the use of a PC-based simulation program (ImpactDose version 1.16, Scanditronix Wellhöver, Schwarzenbruck, Germany). It was determined that the average effective dose was 8.55 mSv for men (range, 7.21 to 10.05 mSv) and 12.24 mSv for women (range, 10.4 to 14.8 mSv).
Image Reconstruction
Retrospectively ECG-correlated image reconstruction was performed with the use of a half-scan reconstruction algorithm that provided a temporal resolution of 165 ms in the center of the scan field. Overlapping axial cross-sectional images with 0.75-mm slice thickness were reconstructed with an increment of 0.5 mm with a medium-sharp convolution kernel (B25f) and an image matrix of 512x512 pixels. The first reconstruction was performed with the reconstruction window starting at 70% of the R-peak-to-R-peak interval. If motion artifacts were present, additional reconstructions in 5% increments and decrements of the R-R interval were performed, as described earlier.13,17,18,22
Data Analysis
The reconstructed image data sets were transferred to an offline workstation (LEONARDO, Siemens Medical Solutions, Forchheim, Germany) for postprocessing. Coronary segments were defined according to the 16-segment model of the American Heart Association/American College of Cardiology guidelines.23 MDCT data sets were evaluated by a single experienced observer blinded to the patients identity, clinical history, and results of invasive coronary angiography. The number and location of bypass grafts, however, were made known to the investigator. Each bypass graft or artery segment was visually classified as either "evaluable" or "unevaluable." Bypass grafts were then assessed for the presence of occlusions. Then all grafts considered patent were visually evaluated for the presence of significant stenosis, defined as a lumen reduction of 50% to 99%. Stenoses were subclassified on the basis of their location in the body of the graft or at the anastomotic site. Finally, all evaluable grafted and nongrafted coronary artery segments, as well as the distal runoff vessels, were visually evaluated for the presence of significant stenoses, also defined as a diameter reduction of >50%. Depending on vessel morphology and quality of data, various postprocessing techniques were applied. Next to assessment of the original transaxial slices, thin-slab maximum intensity projections, double-oblique and curved multiplanar reconstructions, and 3-dimensional, volume-rendered reconstructions were used for evaluation (Figure 1).
|
Quantitative Coronary Angiography
Arterial catheterization and selective conventional angiography of the coronary arteries and bypass grafts, which constituted the standard of reference to validate MDCT, were performed 1 to 3 days after the MDCT procedure. Standard projections were obtained after intracoronary injection of 0.2 mg isosorbide dinitrate and evaluated offline by an independent observer using quantitative coronary angiography software (QuantCor.QCA, PieMedical Imaging, Netherlands). The proximal luminal diameter of all coronary segments and bypass grafts was measured. Segments or grafts with a diameter <1.5 mm were excluded from analysis. In segments with a diameter
1.5 mm, lesions with a lumen reduction of
50% were considered to represent significant stenoses. The diameter stenosis was determined by averaging the luminal narrowing from 2 orthogonal projections.
Statistical Analysis
For the determination of the necessary patient number, the 2-sample proportion test was used. Under the assumption of a sensitivity of 90% for contrast-enhanced, 64-slice MDCT to detect a stenosis of >50% lumen reduction on a per-patient basis,1317 a sample size estimate was performed. Under the assumption that 70% of all patients would have at least 1 coronary stenosis in invasive coronary angiography (the reference standard), it was determined that to estimate a true sensitivity of MDCT of
90% (within 8% of the true value for the detection of patients with at least 1 stenosis), a sample size of
50 patients would be necessary.
Diagnostic accuracy for the detection of significant lesions by MDCT in comparison to quantitative coronary angiography was expressed as sensitivity, specificity, positive predictive value, and negative predictive value. Calculations were performed for the bypass grafts, for the native coronary arteries, and for the combination of nongrafted arteries and the distal runoff vessels on a per-segment and per-vessel basis. In these analyses, segments and vessels classified as unevaluable were excluded.
In addition, per-patient analyses were performed for bypass grafts, for the combination of nongrafted arteries and the distal runoff vessels, and for any significant stenosis in the bypass grafts and the nongrafted arteries/distal runoff vessels. In these analyses, patients with a detectable stenosis in the bypass grafts or the native coronary arteries, as well as patients with at least 1 unevaluable coronary segment, were classified as "positive" (because the presence of a stenosis could not be ruled out and invasive angiography would be the clinical consequence). Patients in whom all grafts and all coronary segments were evaluable and no significant stenosis was present were classified as "negative." Data analysis was performed with the software SPSS 11.0 (SPSS Inc, Chicago, Ill).
The authors had full access to the data and take responsibility for their integrity. All authors have read and agree to the manuscript as written.
| Results |
|---|
|
|
|---|
Bypass Grafts
Invasive coronary angiography demonstrated that 100 of 138 bypass grafts were patent and 38 were occluded. Of the patent grafts, 16 had a significant stenosis. In MDCT, all 138 bypass grafts could be evaluated for patency and occlusion, and all were classified correctly as occluded (n=38) or patent (n=100). All 100 grafts that were classified as patent could be evaluated for the presence of stenoses (50% to 99% diameter reduction). In these 100 grafts, all 16 stenoses were correctly identified by MDCT (sensitivity 100%). Nine of the stenoses were located in the body of the bypass grafts, and 7 stenoses were located at the distal anastomotic site (Figures 2 and 3
). In 79 of 84 bypass grafts, stenoses were correctly ruled out, whereas in 5 cases, the presence of a significant lesion was incorrectly suspected on the basis of MDCT (specificity 94%). In 4 of these cases, the false-positive lesion was located at the distal anastomosis (1 internal mammary artery graft to the left anterior descending coronary artery and 3 venous grafts to the circumflex coronary artery, the first obtuse marginal branch, and the distal right coronary artery, respectively). The remaining false-positive lesion was located in a proximal part of a venous bypass graft to the circumflex coronary artery, and the diameter reduction in quantitative coronary angiography was 28%. Thus, for the detection of significant bypass graft lesions (stenosis or occlusions), a sensitivity of 100% (54/54), specificity of 94% (79/84), negative predictive value of 100% (79/79), and positive predictive value of 92% (54/59) were found.
|
|
Coronary Arteries
For the evaluation of native coronary arteries and distal runoff vessels, analysis was performed on a per-segment basis. Of a total of 800 coronary segments in 50 patients, 135 segments with a diameter <1.5 mm on quantitative coronary angiography and 44 vessel segments distal of 19 total occlusions were excluded from analysis. Thus, 621 coronary segments remained in the analysis. Of these 621 segments, invasive angiography, the standard of reference, classified 111 as having significant stenosis and 510 as being free of stenosis. By MDCT, 55 segments (9%) were classified as unevaluable because of degraded image quality. The reasons were presence of severe calcifications in 41 cases and motion artifacts in 14 cases. In evaluable segments, sensitivity for the detection of significant stenoses was 86% (87/101) with a specificity of 76% (354/465). When unevaluable segments were classified as positive, overall diagnostic accuracy was 73% (451/621) because invasive angiography demonstrated significant stenoses in 10 of 55 unevaluable segments. If the evaluation was restricted to nongrafted arteries and runoff vessels distal to bypass graft anastomoses, a total of 407 coronary segments with a diameter of >1.5 mm were available for analysis. In these 407 segments, invasive coronary angiography demonstrated a significant stenosis in 48 segments and absence of stenosis in 359 segments. By MDCT, 29 of 407 segments (7%) were unevaluable because of calcifications (n=20) or motion artifacts (n=9). In the remaining 378 coronary segments, sensitivity for the detection of significant stenoses (Figures 1 and 4
) was 86% (38/44), with a specificity of 90% (302/334). Invasive coronary angiography demonstrated significant stenoses in 4 of 29 unevaluable segments. The results are summarized in Table 1.
|
|
Per-Patient Analysis
In all per-patient analyses, segments classified as unevaluable were regarded as positive (presence of stenoses) in MDCT. The accuracy for the detection of patients with at least 1 significant graft stenosis by MDCT was 96% (48/50) (sensitivity 100%, specificity 89%). For the detection of at least 1 stenosis in nongrafted arteries and the distal runoff vessels, sensitivity was 97% (35/36) with a specificity of 86% (12/14), which corresponds to an accuracy of 94% (47/50). In 17 patients, at least 1 segment in the nongrafted arteries and distal runoff vessels had been classified as unevaluable by MDCT. In 33 patients, all segments were evaluable. In 1 patient with single-vessel disease, a left anterior descending coronary artery with a lumen reduction of 38% distal to the anastomosis of a patent internal mammary artery graft was classified incorrectly as having a high-grade stenosis in MDCT. In a second patient, a 27% lumen reduction in the mid part of the nongrafted right coronary artery was overestimated by MDCT, whereas the grafts to the left coronary artery as well as the distal runoff vessels and the nongrafted segments demonstrated no significant stenosis. In 1 patient, MDCT failed to detect a significant stenosis of the peripheral right coronary artery distal to the anastomosis of a patent venous bypass graft, whereas normal bypass grafts to the left coronary system as well as normal distal runoff vessels were classified correctly.
Clinically, the most relevant analysis was the ability of MDCT to detect the presence of at least 1 stenosis in the combination of bypass grafts, distal runoff vessels, and nongrafted coronary arteries. In 17 patients, at least 1 coronary segment or bypass graft was classified as unevaluable, and in 18 patients, at least 1 stenosis was correctly detected by MDCT, yielding a sensitivity of 97% (35/36), specificity of 86% (12/14), and overall accuracy of 94% (47 of 50 patients). The results are summarized in Table 2.
|
| Discussion |
|---|
|
|
|---|
2.0 mm were unevaluable for stenosis because of motion artifacts and, especially, severe coronary calcifications.3,10 Compared with previous scanner generations, 64-slice CT provides improved temporal and spatial resolution. Furthermore, with the simultaneous acquisition of 64 slices per rotation, the overall scan time and thus the breathhold time are significantly reduced. With regard to the evaluation of native coronary arteries, 64-slice technology demonstrated a higher diagnostic accuracy for the detection of significant stenoses compared with 16-slice scanners.1317 Only 1 previous study used 64-slice MDCT in patients after bypass surgery,18 but analysis was limited to the grafts and did not include native arteries. In our study, we confirmed their conclusion that accuracy for detection of bypass occlusion and stenosis is high. Without exclusion of any bypass grafts (evaluability 100%), we found a very high diagnostic accuracy in the assessment of graft occlusions (accuracy 100%) and detection of graft stenoses (accuracy 95%). With regard to evaluation of the native coronary arteries, 9% of all coronary segments in native coronary arteries and 7% of segments in nongrafted and distal runoff vessels were unevaluable, mainly because of severe calcifications and, in a smaller number, motion artifacts. After the exclusion of unevaluable segments, diagnostic accuracy for the detection of significant stenoses (defined as a diameter reduction of >50%) was 78% in all native coronary arteries and 90% for the nongrafted and distal runoff vessels. These values are lower than those that studies performed with 64-slice CT had found in patients without previous bypass surgery. In our own study, using the same technology and scan protocol, we achieved a diagnostic accuracy of 97% in 84 patients with suspected coronary artery disease. Only 4% of all coronary artery segments had to be excluded.17 The lower rates for evaluability and accuracy were mainly secondary to the prevalence of severe calcifications, which caused overestimation or, less frequently, underestimation of stenosis severity. Overestimation of stenosis degree is usually the result of the partial volume effect of CT (a consequence of its limited spatial resolution) or of the presence of coronary calcium.24 In these cases, overestimation of stenosis causes false-positive findings, thus decreasing specificity.
Limitations
Besides general limitations of cardiac CT (eg, radiation exposure, use of potentially nephrotoxic contrast agent, and a priori exclusion of patients with atrial fibrillation), the difficulties in the evaluation of severely calcified lesions remain a drawback in the CT evaluation of patients after bypass surgery. Metal clips placed alongside bypass grafts, especially internal mammary artery grafts, have frequently caused artifacts in previous studies.3,6,7,18 These artifacts are often aggravated by motion. In our study, no bypass graft or subsegment of a bypass graft was unevaluable because of the presence of a clip, which may be attributable to the high spatial and temporal resolution, as well as the strict protocol to lower heart rate, that we used. All the same, mainly because of calcifications in the native coronary arteries, only 66% of all patients (33/50) were completely evaluable in our study. Furthermore, the high prevalence of patients with at least 1 coronary or bypass graft stenosissecondary to the fact that individuals with clinical evidence of disease progression constituted our patient populationresulted in high positive predictive values in the per-patient analyses (94% for bypass grafts, 90% for runoff vessels and nongrafted native coronary arteries, and 90% for the combination of bypass grafts, runoff segments, and nongrafted arteries). In a population with lower prevalence of disease, the positive predictive value may be lower, potentially leading to unnecessary invasive procedures if MDCT were used clinically. On the other hand, if MDCT is performed in populations with a high likelihood for progressive disease, the noninvasive procedure will help to avoid only a limited number of cardiac catheterizations (in our study only 12 of 50 patients), with substantial influence on the cost-effectiveness of this approach. A careful assessment of pretest likelihood of disease is therefore necessary before the clinical application of noninvasive imaging such as MDCT in certain patient populations after bypass surgery.
In conclusion, our results demonstrate the ability of 64-slice MDCT to assess the coronary status of patients after bypass surgery. Compared with previous scanner generations, 64-slice technology allows for more reliable evaluation of grafts and especially of the native coronary arteries in patients after bypass surgery. Although analysis can be challenging, the diagnostic accuracy of 94% on a per-patient basis implies that clinical applications may be possible in appropriately selected patient groups.
| Acknowledgments |
|---|
Drs Ropers, Kuettner, Anders, and Achenbach received speakers honoraria from Siemens Medical Solutions. Dr Achenbach has received research grants from Siemens Medical Solutions. The remaining authors report no conflicts.
| References |
|---|
|
|
|---|
Related Article:
Circulation 2006 114: 2305.
This article has been cited by other articles:
![]() |
W T Roberts, J J Bax, and L C Davies Cardiac CT and CT coronary angiography: technology and application Heart, June 1, 2008; 94(6): 781 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hamon, O. Lepage, P. Malagutti, J. W. Riddell, R. Morello, D. Agostini, and M. Hamon Diagnostic Performance of 16- and 64-Section Spiral CT for Coronary Artery Bypass Graft Assessment: Meta-Analysis Radiology, June 1, 2008; 247(3): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schroeder, S. Achenbach, F. Bengel, C. Burgstahler, F. Cademartiri, P. de Feyter, R. George, P. Kaufmann, A. F. Kopp, J. Knuuti, et al. Cardiac computed tomography: indications, applications, limitations, and training requirements: Report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology Eur. Heart J., February 2, 2008; 29(4): 531 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Bateman Business Aspects of Cardiovascular Computed Tomography: Tackling the Challenges J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 111 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Abdulla, S. Z. Abildstrom, O. Gotzsche, E. Christensen, L. Kober, and C. Torp-Pedersen 64-multislice detector computed tomography coronary angiography as potential alternative to conventional coronary angiography: a systematic review and meta-analysis Eur. Heart J., December 2, 2007; 28(24): 3042 - 3050. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons, P. A. Araoz, and E. E. Williamson The Year in Cardiac Imaging J. Am. Coll. Cardiol., September 4, 2007; 50(10): 988 - 1003. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |